The National Australian HCV Point-of-Care Testing Program - Minimal Dataset

ConditionHepatitis C
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKirby Institute

About this trial

The National Australian HCV Point-of-Care Testing Program will establish an observational cohort to evaluate whether scale-up of finger-stick point-of-care HCV testing increases diagnosis and treatment for HCV infection. Participants will be recruited from settings providing services to people with a risk factor for the acquisition of HCV infection (including drug treatment clinics, needle and syringe programs, homelessness settings, mental health services, prisons, and mobile outreach). All participants who undergo HCV point-of-care testing at the study site will be included in the data collection. Participants will not receive treatment as a part of this study. Participants who are HCV RNA positive will be linked to standard of care.

Eligibility criteria

Qualifiers

≥ 18 years of age.

Received point-of-care HCV testing.

Disqualifiers

Nil

Trial design

Treatments tested in this trial

  • Point-of-Care Testing

Treatment groups

40,000 Participants
are divided into 1 treatment group

Sponsors and collaborators

Kirby Institute

Lead sponsor

Flinders University

Collaborator